Daniel Getts

Daniel Getts

Company: Myeloid Therapeutics

Job title: CEO


Harnessing Myeloid Cells To Kill Cancer & Alter The TME 12:30 pm

The functional potential of myeloid cells is unparalleled in the immune system The ATAK myeloid cell platform arms myeloid cells with chimeric antigen receptors with specificity for proteins expressed on tumor cells Innate receptors allow for potent myeloid cell activation after engagement with tumor antigensRead more

day: Clinical Development - Day 1 am

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.